Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer.
暂无分享，去创建一个
L. Cacciari | F. Pannuti | D. Palenzona | F. Spagnolo | A. Martoni | G. Rocchetta | F. Saccani | E. Piana | G. Marra | G. Mattioli | G. Becchi | A. Di Marco | F. Barbanti | W. Persiani | A. D. Marco